Songbird Life Science - Crunchbase Company Profile & Funding

Q: Where is Songbird Life Science's headquarters?

Songbird Life Science is located in Guelph, Ontario, Canada.

Overview

Songbird Life Science

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Songbird Life Science

CB Rank

1912358

Songbird Life Science offers science-based point-of-care rapid testing solutions.

Founded

obfuscation

Private

Guelph, Ontario, Canada

101-250

songbirdlifescience.com

Biotechnology

Life Science

Medical

Medical Device

Key People

Deleo de Leonardis: Co-Founder and CEO
Past Role: Sobeys, Vice President, Private Label
Michael J. Soligo: Co-Founder

Details

Legal Name

Songbird Life Science Inc.

Operating Status

Active

Company Type

For Profit

Founders

Deleo de Leonardis, Michael J. Soligo

Contact Email

hello@songbirdlifescience.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Hyris bCUBE PCR/NAAT Test

A point-of-care PCR rapid test device that identifies SARS-CoV-2 genetic markers with high sensitivity and specificity, delivering results in about two hours.

BTNX Rapid Response COVID-19 IgG/IgM Antibody Rapid Test

A point-of-care antibody test that detects both IgG and IgM antibodies to assess past infection and immune response to SARS-CoV-2, providing results in 15 minutes.